Evidence map›Paper›PMID 41327281›Full record

ArticleStem cell research & therapy2025

Deep-freezing and decontamination strategy for a large autologous bone graft with presentation of the osteogenic potential of resident osteoblasts.

Marija Zekušić, Marija Skoko, Kruno Vukušić, Maja Ledinski, Marina Bujić Mihica, Dejan Blažević, Zlata A Sošić, Mario Đura, Jelena Martinčić, Ivana Vrgoč Zimić and 14 more

Abstract read
In one paragraph

Article in Stem cell research & therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Marija Zekušić *Department of Transfusion and Regenerative Medicine, Sestre milosrdnice University Hospital Center, Zagreb, Croatia. marija.zekusic@kbcsm.hr.
Marija Skoko *Department of Transfusion and Regenerative Medicine, Sestre milosrdnice University Hospital Center, Zagreb, Croatia.
Kruno VukušićDivision of Molecular Biology, Ruđer Bošković Institute, Zagreb, Croatia.
Maja LedinskiDepartment of Transfusion and Regenerative Medicine, Sestre milosrdnice University Hospital Center, Zagreb, Croatia.
Marina Bujić MihicaDepartment of Transfusion and Regenerative Medicine, Sestre milosrdnice University Hospital Center, Zagreb, Croatia.
Dejan BlaževićSchool of Medicine, Catholic University of Croatia, Zagreb, Croatia.
Zlata A SošićDepartment of Drug Science and Technology, University of Turin, Turin, Italy.
Mario ĐuraDivision of Molecular Biology, Ruđer Bošković Institute, Zagreb, Croatia.
Jelena MartinčićDivision of Molecular Biology, Ruđer Bošković Institute, Zagreb, Croatia.
Ivana Vrgoč ZimićDepartment of Transfusion and Regenerative Medicine, Sestre milosrdnice University Hospital Center, Zagreb, Croatia.
Ivanka BatariloDepartment of Microbiology, Croatian Institute of Transfusion Medicine, Zagreb, Croatia.
Denis PolančecGreyledge Europe Ltd, Zagreb, Croatia.
Lucija ZenićGreyledge Europe Ltd, Zagreb, Croatia.
Snježana RamićDepartment of Pathology and Cytology 'Ljudevit Jurak', Sestre milosrdnice University Hospital Center, Zagreb, Croatia.
Patricija SesarDepartment of Pathology and Cytology 'Ljudevit Jurak', Sestre milosrdnice University Hospital Center, Zagreb, Croatia.
Kristina Crkvenac GornikDepartment of Laboratory Diagnostics, Division of Cytogenetics, University Hospital Centre Zagreb, Zagreb, Croatia.
Slaven BabićSchool of Medicine, Catholic University of Croatia, Zagreb, Croatia.
Jure PavešićDepartment of Traumatology, Sestre milosrdnice University Hospital Center, Zagreb, Croatia.
Srećko SabalićDepartment of Traumatology, Sestre milosrdnice University Hospital Center, Zagreb, Croatia.
Iva M TolićDivision of Molecular Biology, Ruđer Bošković Institute, Zagreb, Croatia.
Inga UrlićFaculty of Science, Department of Biology, Zagreb, Croatia.
Stanka Misir ŠitumSchool of Medicine, Catholic University of Croatia, Zagreb, Croatia.
Tiha VučemiloDepartment of Transfusion and Regenerative Medicine, Sestre milosrdnice University Hospital Center, Zagreb, Croatia.
Dinko VidovićDepartment of Traumatology, Sestre milosrdnice University Hospital Center, Zagreb, Croatia.

Funding

European Regional Development Fund KK.01.1.04.0057Hrvatska Zaklada za Znanost IPCH-2022-10-9344QuantiXLie Center of Excellence KK.01.1.01.0004
6 · The paper itself

Abstract

backgroundMusculoskeletal injuries resulting from high-impact trauma often lead to extensive bone defects that require effective reconstruction to prevent limb amputation. However, contamination of large autologous bone grafts in open fractures remains a major clinical challenge. This study aimed to establish a reliable protocol for decontamination of massive autologous bone graft and to assess the viability and regenerative potential of osteoblasts from frozen bone, including the effects of deep freezing and the cryoprotectant dimethyl sulfoxide (DMSO).

methodsA 28 cm femoral segment, extruded during a high-energy road traffic accident, was stored at - 80 °C for 15 days before microbiological analysis revealed contamination. The bone was thawed, decontaminated, and successfully reimplanted. To validate this protocol, femoral head fragments were experimentally contaminated with various microbial strains and treated using the same procedure. To evaluate how low-temperature storage (15 and 30 days, with or without DMSO) impacts osteoblasts, cells were isolated from both fresh and frozen bone and analyzed using a panel of cellular and molecular biology techniques, including histology, flow cytometry, immunofluorescence, gene expression analysis, and real-time imaging.

resultsThe decontamination protocol effectively eliminated microbial contamination from both the clinical autograft and experimentally treated femoral head fragments, with minimal antibiotic residues. Histological analysis confirmed preservation of osteoblasts, osteocytes, and chondrocytes in frozen bone. Osteoblasts from frozen bone retained proliferative and differentiation capacities comparable to those from fresh bone, with no evidence of mitotic chromosomal instability. Cryopreservation with DMSO-containing media slightly increased population doubling time. Expression of RUNX2 was highest in fresh and 15-day frozen bone, while reduced in 30-day samples. No significant differences were observed between DMSO and non-DMSO groups regarding osteogenic potential. ALPL and COL1A1 expression significantly increased after 14 days of osteogenic induction. Time-lapse imaging demonstrated active osteoblast migration and division, and the presence of extracellular vesicles and nanotubes indicated functional cellular communication.

conclusionsThis proof-of-concept study demonstrates that large autologous bone grafts can be frozen and subsequently decontaminated while retaining viable osteoblasts with high proliferative and regenerative potential. By combining a unique and successful clinical case with controlled experimental analyses, the study offers translational relevance, and the findings on osteoblast viability after freezing are promising.

Indexed as

Bone TransplantationCryopreservationDecontaminationOsteoblastsOsteogenesisCell DifferentiationCryoprotective AgentsDimethyl SulfoxideFreezingHumansMaleTransplantation, AutologousCryoprotective AgentsDimethyl SulfoxideAnalysis of antibiotic residuesAutologous boneDecontaminationFemoral heads

Identifiers

PMID41327281
PMCPMC12777315

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.